Skip to main navigation
Allogene Therapeutics
Contact Us
Careers
SHARE
Email Us
Print
Allogene Therapeutics
  • About Us
    • At A Glance
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Partners
    • Our Culture
  • AlloCAR T™
    • History of CAR T
    • Next Revolution in Cell Therapy
    • Platform for Tomorrow
    • ALLOGENEIC CELL THERAPY STRATEGY
    • On-demand Availability
  • Pipeline
    • Clinical Trials
    • Expanded Access
    • Scientific Publications
  • Our Culture
    • ESG Report
    • We are one Allogene
    • REVOLUTIONIZING CELL THERAPY
    • DIVERSITY, EQUITY AND INCLUSION
    • JOIN THE ALLOGENE COMMUNITY
  • News Center
    • Events
    • Press Releases
    • Perspectives
    • Our Tweets
    • Media Resources
    • Community Guidelines
  • INVESTORS
    • IR Overview
    • News & Events
      • Press Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Corporate Governance
      • Documents & Charters
      • ESG Report
      • Board of Directors
      • Management
      • Committee Composition
    • SEC Filings
    • Resources
      • Investor FAQs
      • Email Alerts
      • IR Inquiry

Committee Composition

Audit Committee Compensation Committee International and Business Development Oversight Committee Nominating and Corporate Governance Committee
Liz Barrett Audit Committee
David Bonderman Compensation Committee
John DeYoung Compensation Committee International and Business Development Oversight Committee
Franz Humer, Ph.D. Audit Committee Compensation Committee International and Business Development Oversight Committee
Joshua Kazam International and Business Development Oversight Committee
Debbie Messemer Audit Committee Nominating and Corporate Governance Committee
Vicki Sato International and Business Development Oversight Committee
Todd Sisitsky Nominating and Corporate Governance Committee
Owen Witte, M.D. Nominating and Corporate Governance Committee
= Chairperson = Member = Lead Director = Financial Expert
Print Page
Email Alerts
RSS Feeds
Investor Contacts
Facebook
Twitter
LinkedIn
E-Mail
Tumblr
Reddit
WhatsApp
Telegram
Allogene Therapeutics
CONNECT

210 E. Grand Avenue
South San Francisco, CA 94080

View Map / Contact Us

  • About Us
  • At a Glance
  • Management Team
  • Board of Directors
  • Scientific Advisors
  • Partners
  • Our Culture
  • ALLOCAR T™
  • History of CAR T
  • Next Revolution in Cell Therapy
  • Platform for Tomorrow
  • Allogeneic Cell Therapy Strategy
  • On-Demand Availability
  • Pipeline
  • Clinical Trials
  • Expanded Access
  • Scientific Publications
  • News Center
  • Events
  • Press Releases
  • Perspectives
  • Our Tweets
  • Media Resources
  • Community Guidelines
  • Investors
  • IR Overview
  • News and Events
    • Press Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Look Up
    • Investment Calculator
  • Corporate Governance
    • Documents & Charters
    • ESG Report
    • Board of Directors
    • Management
    • Committee Composition
  • SEC Filings
  • Resources
  • Investor FAQS
  • Email Alerts
  • IR Inquiry
©2023 Allogene Therapeutics
TERMS OF USE
PRIVACY POLICY
PREFERENCE CENTER